Retinalamin
Also known as: Retinalamin
Retinalamin is a polypeptide and nucleoprotein complex extracted from the retina of cattle, used in some regions as a retinoprotective agent for degenerative and dystrophic eye conditions.
Last updated
Mechanism of Action
Retinalamin is a tissue-derived peptide-nucleotide bioregulator believed to act on retinal cells by stimulating metabolic activity in the neurosensory retina and pigment epithelium. It is reported to modulate photoreceptor and pigment-epithelium function, improve the functional interaction of retinal layers, and exert antioxidant and reparative effects that reduce lipid peroxidation. These actions are proposed to enhance retinal microcirculation and accelerate recovery of light-sensitivity following degenerative injury, though mechanisms remain incompletely defined by Western standards.
- Half-life
- Not well characterized; presumed short for component peptides
- Administration Routes
- intramuscular, subcutaneous
- Research Status
- Research Chemical
Reported Benefits
- Studied for retinal dystrophies and degenerative eye disease
- Reported antioxidant activity in ocular tissue
- May support photoreceptor and pigment-epithelium metabolism
- Investigated as an adjunct in diabetic retinopathy
- Proposed to improve retinal microcirculation
Potential Side Effects
- Injection-site reactions
- Allergic or hypersensitivity reactions to animal-derived protein
- Potential immunogenicity
- Limited rigorous safety data outside regional use
Common Dosing
Regional clinical protocols have used roughly 5 mg per intramuscular injection over a course of about 10 days; this is for research reference only and not personal medical advice.
The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.
Contraindications
- Known hypersensitivity to bovine-derived proteins
- Pregnancy and breastfeeding
- Not validated by FDA or EMA for therapeutic use
Cortexin
Cortexin is a polypeptide complex extracted from cerebral cortex tissue, used clinically in Russia and several other countries as a neuroprotective and nootropic agent. In Western markets it is sold as a research chemical. (Cortexin is a registered polypeptide drug in some countries; presented here for educational/research reference only, not as medical guidance.)
Epitalon
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the pineal peptide epithalamin, studied for telomerase activation, circadian regulation, and longevity in animal and limited human research.
- View
[The influence of long-term retinal protective therapy on glaucoma progression according to structural and functional tests]
2020
- View
[Application of Retinalamin for the treatment of glaucomatous optic neuropathy]
2014
- View
[Retinoprotective effects of Retinalamin studied in an experimental model of photochemical damage to rabbit retinas]
2021
- View
[Investigation of ligand-receptor interaction and biodistribution of a drug containing cattle retinal polypeptides in various administration routes]
2021
- View
[Structural and functional changes in the retina of patients with primary open-angle glaucoma and compensated intraocular pressure while undergoing retinoprotective therapy].
2019